Eli Lilly Other Non-Current Liabilities 2010-2024 | LLY

Eli Lilly other non-current liabilities for the quarter ending September 30, 2024 were $6.118B, a 13.84% increase year-over-year.

  • Eli Lilly other non-current liabilities for 2023 were $6.09B, a 10.05% increase from 2022.
  • Eli Lilly other non-current liabilities for 2022 were $5.534B, a 0.55% decline from 2021.
  • Eli Lilly other non-current liabilities for 2021 were $5.564B, a 0.34% increase from 2020.

Eli Lilly Other Non-Current Liabilities 2010-2024 | LLY

  • Eli Lilly other non-current liabilities for 2023 were $6.09B, a 10.05% increase from 2022.
  • Eli Lilly other non-current liabilities for 2022 were $5.534B, a 0.55% decline from 2021.
  • Eli Lilly other non-current liabilities for 2021 were $5.564B, a 0.34% increase from 2020.
Related Stocks
Company NameMarket
Cap
Novo Nordisk (NVO)$460.6B
Johnson & Johnson (JNJ)$368.4B
AbbVie (ABBV)$294.4B
Merck (MRK)$244.2B
Novartis AG (NVS)$211.1B
AstraZeneca (AZN)$197.8B
Pfizer (PFE)$142.2B
Sanofi (SNY)$121.8B
Innoviva (INVA)$1.2B